Ebola


FDA Approves Ebola Treatment

On December 21, the U.S. Food and Drug Administration approved Ebanga (Ansuvimab-zykl), a human monoclonal antibody, for the treatment of ebola (zaire ebolavirus) infection in…


FDA Approves First Treatment for Ebola

On October 14, through immediate press-release FDA (Food and Druf Administration of U.S.) approved Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three monoclonal antibodies,…